The DOI matches its Crossref record, with a small difference in title or year; 34 of the 35 references it cites were found in a registry or an index.
Estrogen plus Progestin and the Risk of Coronary Heart Disease
Open accessAbstract
BACKGROUND: Recent randomized clinical trials have suggested that estrogen plus progestin does not confer cardiac protection and may increase the risk of coronary heart disease (CHD). In this report, we provide the final results with regard to estrogen plus progestin and CHD from the Women's Health Initiative (WHI). METHODS: The WHI included a randomized primary-prevention trial of estrogen plus progestin in 16,608 postmenopausal women who were 50 to 79 years of age at base line. Participants were randomly assigned to receive conjugated equine estrogens (0.625 mg per day) plus medroxyprogesterone acetate (2.5 mg per day) or placebo. The primary efficacy outcome of the trial was CHD (nonfatal myocardial infarction or death due to CHD). RESULTS: After a mean follow-up of 5.2 years (planned duration, 8.5 years), the data and safety monitoring board recommended terminating the estrogen-plus-progestin trial because the overall risks exceeded the benefits. Combined hormone therapy was associated with a hazard ratio for CHD of 1.24 (nominal 95 percent confidence interval, 1.00 to 1.54; 95 percent confidence interval after adjustment for sequential monitoring, 0.97 to 1.60). The elevation in risk was most apparent at one year (hazard ratio, 1.81 [95 percent confidence interval, 1.09 to 3.01]). Although higher base-line levels of low-density lipoprotein cholesterol were associated with an excess risk of CHD among women who received hormone therapy, higher base-line levels of C-reactive protein, other biomarkers, and other clinical characteristics did not significantly modify the treatment-related risk of CHD. CONCLUSIONS: Estrogen plus progestin does not confer cardiac protection and may increase the risk of CHD among generally healthy postmenopausal women, especially during the first year after the initiation of hormone use. This treatment should not be prescribed for the prevention of cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although there have been no placebo-controlled trials in children, observational studies have suggested that early treatment can reduce LDL-C burden, improve endothelial function, substantially attenuate the development of atherosclerosis, and improve coronary outcomes [369-371].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [371]
In the citing paper
“Although there have been no placebo-controlled trials in children, observational studies have suggested that early treatment can reduce LDL-C burden, improve endothelial function, substantially attenuate the development of atherosclerosis, and improve coronary outcomes [369-371].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [371]
In the citing paper
“Although there have been no placebo-controlled trials in children, observational studies have suggested that early treatment can reduce LDL-C burden, improve endothelial function, substantially attenuate the development of atherosclerosis, and improve coronary outcomes [369-371].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [371]
In the citing paper
“Although there have been no placebo-controlled trials in children, observational studies have suggested that early treatment can reduce LDL-C burden, improve endothelial function, substantially attenuate the development of atherosclerosis, and improve coronary outcomes [369-371].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [371]
In the citing paper
“Oestrogen replacement therapy, despite some favourable effects on the lipid profile, has not been demonstrated to reduce CV risk and cannot be recommended for CV prevention in women.166”
From ESC/EAS Guidelines for the management of dyslipidaemias (2011) · cites this paper as [166]
In the citing paper
“Oestrogen replacement therapy, despite some favourable effects on the lipid profile, has not been demonstrated to reduce CV risk and cannot be recommended for CVD prevention in women. 318”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [318]
In the citing paper
“and the higher palatability and acceptance of MeDiets in comparison with low-fat diets 17,18 lend support to our hypothesis.”
From Cohort Profile: Design and methods of the PREDIMED study (2012) · cites this paper as [18]
In the citing paper
“Oestrogen replacement therapy, despite some favourable effects on the lipid profile, has not been demonstrated to reduce CV risk and cannot be recommended for CVD prevention in women.318”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [318]
In the citing paper
“however, hormone replacement therapy does not consistently restore BP, suggesting additional regulatory mechanisms [ 177 ].”
From Sex differences in potassium regulation: evidence, molecular mechanisms and clinical implications (2026) · cites this paper as [177]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
The Protective Effects of Estrogen on the Cardiovascular System
Mendelsohn, M. E., & Karas, R. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906103402306 · Cited by 3,119
Grundy, S. M., Benjamin, I. J., Burke, G. L., Chait, A., Eckel, R. H., Howard, B. V., Mitch, W., Smith, S. C., & Sowers, J. R. (1999) · Circulation · doi:10.1161/01.cir.100.10.1134 · Cited by 2,698
Design of the Women’s Health Initiative Clinical Trial and Observational Study
The Women’s Health Initiative Study Group (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00078-0 · Cited by 2,580
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
Grady, D., Rubin, S. M., Petitti, D. B., Fox, C. S., Black, D. M., Ettinger, B. B., Ernster, V. L., & Cummings, S. R. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-1016 · Cited by 2,329
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy
Grady, D. G., Herrington, D. M., Bittner, V., Blumenthal, R. S., Davidson, M., Hlatky, M. A., Hsia, J. A., Hulley, S. B., Herd, A. J., Khan, S. S., et al. (2002) · JAMA · doi:10.1001/jama.288.1.49 · Cited by 1,921
Self-citationEffect of Statin Therapy on C-Reactive Protein Levels
Albert, M. A., Danielson, E., Rifai, N., Ridker, P. M., & for the PRINCE Investigators (2001) · JAMA · doi:10.1001/jama.286.1.64 · Cited by 1,644
Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis
Herrington, D. M., Reboussin, D. M., Brosnihan, K. B., Sharp, P. C., Shumaker, S. A., Snyder, T. E., Furberg, C. D., Kowalchuk, G. J., Stuckey, T. D., Rogers, W. J., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008243430801 · Cited by 1,242
Flagged first, then by citations
1 of the 35 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 701–800 of 1,001
Lee, S.-S., Singh, S., Magder, L., & Petri, M. (2008) · Lupus · doi:10.1177/0961203307085878 · Cited by 30
Wang, G., Sui, L., Gai, P. Y., Li, G., Qi, X., & Jiang, X. (2017) · Bone and Joint Research · doi:10.1302/2046-3758.67.bjr-2016-0292.r1 · Cited by 30
The effects of black cohosh therapies on lipids, fibrinogen, glucose and insulin
Spangler, L., Newton, K. M., Grothaus, L. C., Reed, S. D., Ehrlich, K. J., & LaCroix, A. Z. (2007) · Maturitas · doi:10.1016/j.maturitas.2007.01.002 · Cited by 30
Estradiol increases angiotensin II type 1 receptor in hearts of ovariectomized rats
Ricchiuti, V., Lian, C. G., Oestreicher, E. M., Tran, L., Stone, J. R., Yao, T. M., Seely, E. W., Williams, G. H., & Adler, G. K. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0199 · Cited by 30
Subramanian, M., Balasubramanian, P., Garver, H. S., Northcott, C. A., Zhao, H., Haywood, J. R., Fink, G. D., MohanKumar, S. M. J., & MohanKumar, P. S. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00020.2011 · Cited by 30
Seli, E. U., Guzeloglu‐Kayisli, O., Çakmak, H., Kayisli, U. A., Selam, B., & Arici, A. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1225 · Cited by 30
Non-ST Elevation Acute Coronary Syndromes: A Comprehensive Review
Bob‐Manuel, T., Ifedili, I., Reed, G. L., Ibebuogu, U. N., & Khouzam, R. N. (2017) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2017.04.006 · Cited by 33
Women, hormones, and clinical trials: a beginning, not an end
Miller, V. M., Clarkson, T. B., Harman, S. M., Brinton, E. A., Cedars, M. I., Løbo, R. A., Manson, J. E., Merriam, G. R., Naftolin, F. N., & Santoro, N. F. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00248.2005 · Cited by 30
Self-citationArzoxifene: the development and clinical outcome of an ideal SERM
Münster, P. N. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.3.317 · Cited by 30
Fernandes, E. O., Moraes, R. S., Ferlin, E. L., Wender, M. C. O., & Ribeiro, J. P. (2005) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2005.00041.x · Cited by 30
Nuclear receptors in disease: the oestrogen receptors
Nilsson, M., Dahlman‐Wright, K., & Gustafsson, J.-Α. (2004) · Essays in Biochemistry · doi:10.1042/bse0400157 · Cited by 30
Radiotherapy for Breast Cancer
Cuzick, J. M. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji086 · Cited by 30
Microphysiological modeling of the reproductive tract: A fertile endeavor
Eddie, S. L., Kim, J. J., Woodruff, T. K., & Burdette, J. E. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214529387 · Cited by 29
Factors related to menopausal symptom management decisions
Carpenter, J. S., Byrne, M. M., & Studts, J. L. (2011) · Maturitas · doi:10.1016/j.maturitas.2011.06.002 · Cited by 29
Ospemifene use in postmenopausal women
Gennari, L., Merlotti, D., Valleggi, F., & Nuti, R. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902953715 · Cited by 29
Hatch, N. W., Srodulski, S. J., Chan, H.-W., Zhang, X., Tannock, L. R., & King, V. L. (2012) · Gender Medicine · doi:10.1016/j.genm.2012.08.003 · Cited by 29
Androgen deficiency and type 2 diabetes mellitus
Gibb, F. W., & Strachan, M. W. J. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.04.004 · Cited by 29
Primary prevention of coronary heart disease in women
Rees, M., & Stevenson, J. C. (2008) · Menopause international · doi:10.1258/mi.2007.007037 · Cited by 29
Women's Willingness to Accept Perceived Risks for Vasomotor Symptom Relief
Johnson, F. R., Özdemir, S., Hauber, B., & Kauf, T. L. (2007) · Journal of Women s Health · doi:10.1089/jwh.2006.0218 · Cited by 29
Guía sobre el manejo de la angina estable. Versión resumida
Estable, G. D. T. D. L. S. E. D. C. S. E. M. D. L. A. (2006) · Revista Española de Cardiología · doi:10.1157/13092800 · Cited by 29
HRT, osteoporosis and regulatory authorities Quis custodiet ipsos custodes?
Stevenson, J. C. (2006) · Human Reproduction · doi:10.1093/humrep/del043 · Cited by 29
Fu, S., Zhao, Y., Ren, M., Zhang, J., Wang, Y., Han, L., Chang, Y., Fan, G., Wang, H., Huang, Y., et al. (2015) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000534 · Cited by 29
Smolders, R. G. V., de Meer, K., Kenemans, P., Jakobs, C., Kulik, W., & van der Mooren, M. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1021 · Cited by 29
Meyer, M. R., Haas, E., & Barton, M. (2008) · Gender Medicine · doi:10.1016/j.genm.2008.03.004 · Cited by 30
Estrogen Replacement Therapy and Retinal Vascular Caliber
Wong, T. Y., Knudtson, M. D., KLEIN, B., Klein, R., & HUBBARD, L. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2004.11.026 · Cited by 30
Potentially Inappropriate Prescribing for Elderly Patients in 2 Outpatient Settings
Maio, V., Hartmann, C. W., Poston, S. A., Liu-Chen, X., Diamond, J. J., & Arenson, C. A. (2006) · American Journal of Medical Quality · doi:10.1177/1062860605285475 · Cited by 29
Beral, V., REEVES, G. K., & Banks, E. (2005) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2005.00541.x · Cited by 29
Lemaître, R. N., Weiss, N. S., Smith, N. L., Psaty, B. M., Lumley, T., Larson, E. B., & Heckbert, S. R. (2006) · Archives of Internal Medicine · doi:10.1001/.399 · Cited by 29
Self-citationWathen, C. N. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1030756 · Cited by 29
Hormones, Metabolism, Aging and Men's Health
Buvat, J., Shabsigh, R., Guay, A. T., Gooren, L. J., Torres, L. O., MEULEMAN, E. J. H., & Graziottin, A. (2006) · Wiley eBooks · doi:10.1002/9780470755235.ch18 · Cited by 29
Lee, G. B., Nam, G. E., Kim, W., Han, B., Cho, K.-H., Kim, S. M., Choi, Y. S., Kim, D., Park, Y. G., Jung, J., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.030117 · Cited by 31
Santen, R. J., Kagan, R., Altomare, C. J., Komm, B. S., Mirkin, S., & Taylor, H. S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3680 · Cited by 28
New evidence for cardiac benefit of postmenopausal hormone therapy
Mikkola, T. S., Savolainen-Peltonen, H. M., Venetkoski, M., & Ylikorkala, O. (2017) · Climacteric · doi:10.1080/13697137.2016.1262839 · Cited by 28
A heartfelt message, estrogen replacement therapy: use it or lose it
Speth, R. C., D’Ambra, M., Ji, H., & Sandberg, K. L. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00041.2018 · Cited by 30
Pharmacotherapeutic approaches to treating depression during the perimenopause
Garay, R. P., Charpeaud, T., Logan, S. J. S., Hannaert, P. A., Garay, R. G., Llorca, P., & Shorey, S. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1645122 · Cited by 28
Ortmann, O., Beckermann, M. J., Inwald, E. C., Strowitzki, T., Windler, E. E. T., Tempfer, C. M., & For the guideline group (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05682-4 · Cited by 28
Hormone therapy and postural balance in elderly women
Naessén, T., Lindmark, B., & Larsen, H. C. (2007) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3180592b0e · Cited by 28
McBane, S. E., Borgelt, L. M., Barnes, K. N., Westberg, S. M., Lodise, N. M., & Stassinos, M. G. (2014) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1394 · Cited by 29
Chen, C.-C., Lin, C., & Lee, T. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.11.050 · Cited by 28
Menopausal hot flushes and vascular health
Tuomikoski, P., Ylikorkala, O., & Mikkola, T. S. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.546364 · Cited by 28
Molvarec, A., Nagy, B., Kovács, M., Walentin, S., Imreh, É., Rigó, J. J., Szalay, J., Füst, G., Prohászka, Z., & Karádi, I. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.02.005 · Cited by 28
Choi, S. D., Steinberg, E. M., Lee, H., & Naftolin, F. N. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181e97344 · Cited by 28
Jackson, R. D., & Shidham, S. (2007) · Current Osteoporosis Reports · doi:10.1007/s11914-007-0010-4 · Cited by 28
Cann, J. A., Register, T. C., Adams, M. R., Clair, R. W. S., Espeland, M. A., & Williams, J. K. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.01.018 · Cited by 28
Kühl, H., & Stevenson, J. C. (2006) · Gynecological Endocrinology · doi:10.1080/09513590600717368 · Cited by 28
Hormone-Replacement Therapy and Cardiovascular Diseases
Bailar, J. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmp038110 · Cited by 28
Chlebowski, R. T., Anderson, G. L., Geller, M. L., & Col, N. F. (2006) · Clinical Breast Cancer · doi:10.3816/cbc.2006.s.005 · Cited by 28
Fu, X., Cui, Y., Lin, G., & Wang, T. (2007) · Gynecological Endocrinology · doi:10.1080/09513590601181457 · Cited by 28
Postmenopausal Hormone Therapy and Atherosclerosis — Time Is of the Essence
Keaney, J. F., & Solomon, C. G. (2016) · New England Journal of Medicine · doi:10.1056/nejme1602846 · Cited by 28
Implications of Gender Difference in Coronary Calcification as Assessed by CT Coronary Angiography
Makaryus, A. N., Sison, C. P., Kohansieh, M., & Makaryus, J. N. (2014) · Clinical Medicine Insights Cardiology · doi:10.4137/cmc.s18764 · Cited by 27
Menopausal hormone treatment cardiovascular disease: another look at an unresolved conundrum
Harman, S. M. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.02.042 · Cited by 27
Miller, V. M., Jenkins, G. D., Biernacka, J. M., Heit, J. A., Huggins, G. S., Hodis, H. N., Budoff, M. J., Løbo, R. A., Taylor, H. S., Manson, J. E., et al. (2015) · Physiological Genomics · doi:10.1152/physiolgenomics.00029.2015 · Cited by 27
Self-citationModulation of High-Density Lipoprotein Cholesterol Metabolism and Reverse Cholesterol Transport
Hersberger, M., & von Eckardstein, A. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-27661-0_20 · Cited by 27
Effect of hormone therapy and calcitriol on serum lipid profile in postmenopausal older women
Sai, A. J., Gallagher, J. C., & Fang, X. (2011) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e318217d41d · Cited by 27
Cimicifuga racemosaextract for relieving menopausal symptoms: a randomized controlled trial
Tanmahasamut, P., Vichinsartvichai, P., Rattanachaiyanont, M., Techatraisak, K., Dangrat, C., & Sardod, P. (2014) · Climacteric · doi:10.3109/13697137.2014.933410 · Cited by 27
The prevention of osteoporotic fractures
Karlsson, M. K., Gerdhem, P., & Ahlborg, H. G. (2005) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.87b10.16578 · Cited by 27
Differential regulation of endothelium behavior by progesterone and medroxyprogesterone acetate
Cutini, P. H., Campelo, A. E., & Massheimer, V. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0263 · Cited by 27
Peters, S. A. E., den Ruijter, H. M., Grobbee, D. E., & Bots, M. L. (2012) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.112.978114 · Cited by 30
Hellevik, A. I., Nordsletten, L., Johnsen, M. B., Fenstad, A. M., Furnes, O. N., Storheim, K., Zwart, J., Flugsrud, G. B., & Langhammer, A. (2017) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2017.06.010 · Cited by 27
Parks, R. J., Bogachev, O., Mackasey, M., Ray, G., Rose, R. A., & Howlett, S. E. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.07.118 · Cited by 27
Bacciottini, L., Falchetti, A., Pampaloni, B., Bartolini, E., Carossino, A. M., & Brandi, M. L. (2006) · CRC Press eBooks · doi:10.1201/b14631-25 · Cited by 27
Postmenopausal Estrogen for Treatment of Hot Flashes
Nelson, H. D. (2004) · JAMA · doi:10.1001/jama.291.13.1621 · Cited by 27
Synthesising licensing data to assess drug safety
McPherson, K., & Hemminki, E. (2004) · BMJ · doi:10.1136/bmj.328.7438.518 · Cited by 27
Hormones, menopause, and heart disease: Making sense of the Women’s Health Initiative
Derry, P. S. (2004) · Women s Health Issues · doi:10.1016/j.whi.2004.07.004 · Cited by 27
Should symptomatic menopausal women be offered hormone therapy?
Løbo, R. A., Bélisle, S., Creasman, W. T., Frankel, N. R., Goodman, N., Hall, J. E., Ivey, S. L., Kingsberg, S. A., Langer, R., Lehman, R., et al. (2006) · PubMed Central · Cited by 27
Shahnazi, M., Nahaee, J., Mohammad‐Alizadeh‐Charandabi, S., & Bayatipayan, S. (2013) · PubMed Central · doi:10.5681/jcs.2013.013 · Cited by 26
Anagnostis, P. G., Majeed, A., Johnston, D. G., & Godsland, I. F. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0401 · Cited by 26
Progestins Affect Mechanism of Estrogen-induced C-reactive Protein Stimulation
Reuben, D. B., Palla, S. L., Hu, P., Reboussin, B. A., Crandall, C. J., Herrington, D. M., Barrett-Connor, E. L., & Greendale, G. A. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.08.012 · Cited by 26
Drospirenone and its antialdosterone properties
Genazzani, A. R., Mannella, P., & Simoncini, T. (2007) · Climacteric · doi:10.1080/13697130601114891 · Cited by 26
Cattran, D., Reich, H., Kim, S., & Troyanov, S. (2011) · American Society of Nephrology. Clinical Journal · doi:10.2215/cjn.11001210 · Cited by 28
Rossouw, J. E., Prentice, R. L., Manson, J. E., Aragaki, A. K., Hsia, J. A., Martin, L. W., Kuller, L. H., Johnson, K., Eaton, C. B., Jackson, R. D., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.103218 · Cited by 26
Self-citationArcher, S. L., Gragasin, F. S., Webster, L., Bochinski, D. J., & Michelakis, E. D. (2005) · Drugs & Aging · doi:10.2165/00002512-200522100-00003 · Cited by 26
Measures for Conducting Comparative Benefit: Risk Assessment
Chuang‐Stein, C., Entsuah, R., & Pritchett, Y. (2008) · Drug Information Journal · doi:10.1177/009286150804200304 · Cited by 26
Epidemiology of Age-Related Macular Degeneration
Seddon, J. M., & Chen, C. A. (2006) · Elsevier eBooks · doi:10.1016/b978-0-323-02598-0.50064-1 · Cited by 26
Hemelaar, M., van der Mooren, M. J., van Baal, W. M., Schalkwijk, C. G., Kenemans, P., & Stehouwer, C. D. A. (2005) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000153888.94399.af · Cited by 26
Differential estrogen signaling in endothelial cells upon pulsed or continuous administration
Simoncini, T., Fornari, L., Mannella, P., Varone, G. L., Caruso, A., Garibaldi, S., & Genazzani, A. R. (2004) · Maturitas · doi:10.1016/j.maturitas.2004.04.001 · Cited by 26
Combination therapy for treatment of osteoporosis: A review
Pinkerton, J. V., & Dalkin, A. C. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.07.022 · Cited by 26
HRT and the primary prevention of cardiovascular disease
Stevenson, J. C. (2007) · Maturitas · doi:10.1016/j.maturitas.2007.02.007 · Cited by 26
Zaitseva, M., Yue, D. S., Katzenellenbogen, J. A., Rogers, P. A. W., & Gargett, C. E. (2004) · Journal of the Society for Gynecologic Investigation · doi:10.1016/j.jsgi.2004.06.004 · Cited by 26
Vitamin D Status and Cancer Incidence and Mortality: Something New Under the Sun
Schwartz, G. G., & Blot, W. J. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj127 · Cited by 26
Kretzschmar, G., Nißlein, T., Zierau, O., & Vollmer, G. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.05.008 · Cited by 26
Guidelines for estimating causal effects in pragmatic randomized trialsPreprint
Murray, E. J., Swanson, S. A., & Hernán, M. Á. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1911.06030 · Cited by 27
Stram, D. O., Liu, Y., Henderson, K. D., Sullivan‐Halley, J., Luo, J., Saxena, T., Reynolds, P., Chang, E. T., Neuhausen, S. L., Horn‐Ross, P. L., et al. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181f0839a · Cited by 25
Causal inference challenges in social epidemiology: Bias, specificity, and imagination
Glymour, M. M., & Rudolph, K. E. (2016) · Social Science & Medicine · doi:10.1016/j.socscimed.2016.07.045 · Cited by 25
Silva, F. S., Sóter, M. O., Sales, M. F., Cândido, A. L., dos Reis, F. M., Silva, I. D. F. O., Sousa, M. O., Ferreira, C. N., & Gomes, K. B. (2015) · Gene · doi:10.1016/j.gene.2015.01.037 · Cited by 25
Prevention and treatment of venous thromboembolism during HRT: current perspectives
Rott, H. (2014) · International Journal of General Medicine · doi:10.2147/ijgm.s46310 · Cited by 25
Activation of Nitric Oxide Synthesis in Human Endothelial Cells Using Nomegestrol Acetate
Simoncini, T., Caruso, A., Garibaldi, S., Fu, X., Giretti, M. S., Baldacci, C., Scorticati, C., Fornari, L., Mannella, P., & Genazzani, A. R. (2006) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000233184.64531.84 · Cited by 25
Pentti, K., Honkanen, R., Tuppurainen, M. T., Sandini, L., Kröger, H., & Saarikoski, S. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02059 · Cited by 25
Arias-Loza, P.-A., Muehlfelder, M., Elmore, S. A., Maronpot, R. R., Hu, K., Blode, H., Hegele‐Hartung, C., Fritzemeier, K. H., Ertl, G., & Pelzer, T. (2009) · Toxicologic Pathology · doi:10.1177/0192623309350475 · Cited by 25
Combined low-dose LiCl and LY294002 for the treatment of osteoporosis in ovariectomized rats
Bai, J., Xu, Y., Dieo, Y., & Sun, G. (2019) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-019-1210-1 · Cited by 25
Henríquez, M. S., Jódar, E., Arbelo, E., Domı́nguez, C., Saavedra, P., Torres, A., SALIDO, E. C., Limiñana, J. M., de Tejada, M. J. G., & Hernández, D. (2004) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2004.04.009 · Cited by 25
Purnell, J. Q., Bland, L. B., Garzotto, M., Lemmon, D., Wersinger, E. M., Ryan, C. W., Brunzell, J. D., & Beer, T. M. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500276-jlr200 · Cited by 25
Use of dydrogesterone in hormone replacement therapy
Mueck, A. O., Seeger, H., & Bühling, K. J. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.09.013 · Cited by 25
Jeanes, H. L., Wanikiat, P., Sharif, I., & Gray, G. A. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000196593.44335.eb · Cited by 25
Risk of stroke and hormone replacement therapy
Li, C., Engström, G., Hedblad, B., Berglund, G. L., & Janzon, L. (2005) · Maturitas · doi:10.1016/j.maturitas.2005.10.002 · Cited by 25
The Effects of Estrogen on Brain Function
Rasgon, N. (2006) · Johns Hopkins University Press eBooks · doi:10.1353/book.3239 · Cited by 25
Where are we now with hormone replacement therapy?
McPherson, K. (2004) · BMJ · doi:10.1136/bmj.328.7436.357 · Cited by 25
Lancaster, T. S., Jefferson, S. J., & Korzick, D. H. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00851.2010 · Cited by 24
17β-Estradiol promotes sex-specific dysfunction in isolated human arterioles
SenthilKumar, G., Katunaric, B., Bordas-Murphy, H., Young, M. S., Doren, E. L., Schulz, M. E., Widlansky, M. E., & Freed, J. K. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00708.2022 · Cited by 24
Vestergaard, P. (2011) · Calcified Tissue International · doi:10.1007/s00223-011-9549-2 · Cited by 24
Metadata
- Authors
- Manson, J. E., Hsia, J., Johnson, K. C., Rossouw, J. E., Assaf, A. R., Lasser, N. L., Trevisan, M., Black, H. R., Heckbert, S. R., Detrano, R., Strickland, O. L., Wong, N. D., Crouse, J. R., Stein, E., & Cushman, M.
- Affiliations
- Brigham and Women's Hospital (US)
- George Washington University (US)
- University of Tennessee Health Science Center (US)
- National Heart, Lung, and Blood Institute (US)
- Memorial Hospital of Rhode Island (US)
- Rutgers New Jersey Medical School (US)
- University at Buffalo, State University of New York (US)
- Rush University Medical Center (US)
- University of Washington (US)
- University of California, Los Angeles (US)
- Emory University (US)
- University of California, Irvine (US)
- Wake Forest University (US)
- University of Vermont (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-08-07
- Volume
- 349
- Issue
- 6
- Pages
- 523-534
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1981922048
- Cited by
- 2,065
- References
- 35
- Citations by year
- 2026: 32 · 2025: 43 · 2024: 34 · 2023: 32 · 2022: 33 · 2021: 43 · 2020: 51 · 2019: 48 · 2018: 51 · 2017: 59 · 2016: 42 · 2015: 67 · 2014: 73 · 2013: 109 · 2012: 99
- FWCI
- 123.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- estrogen plus progestin, coronary artery disease, hormone replacement therapy, Women's Health Initiative, postmenopausal women, conjugated equine estrogens, medroxyprogesterone acetate, myocardial infarction, cardiovascular risk, LDL cholesterol, C-reactive protein, trial termination
- MeSH terms
- Aged, Coronary Disease, Double-Blind Method, Drug Combinations, Estrogens, Conjugated (USP), Female, Follow-Up Studies, Heart Diseases, Humans, Middle Aged, Myocardial Infarction, Risk Factors, Proportional Hazards Models, Case-Control Studies, Treatment Outcome, Medroxyprogesterone Acetate, Postmenopause, Hormone Replacement Therapy, Progesterone Congeners
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
